Xue-Min Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xue-Min Li has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Caiqin Wu
School of Nursing Shanghai University of Traditional Chinese Medicine Shanghai China
2 shared publications Shan Wang
School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
2 shared publicationsJieting Jiang
Oncology department, Guiqian International General Hospital, Guiyang, China
1 shared publicationKun-Peng Li
School of Exercise and Health, Shanghai University of Sport, Shanghai, 200438, China
1 shared publicationKunpeng Li
School of Exercise and Health, Shanghai University of Sport, Shanghai, China
1 shared publicationLi-Bing Liang
School of Nursing, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Effects of Baduanjin combined with cognitive training in older adults with mild cognitive impairment of mixed etiologies: a study protocol for a randomized controlled trial
Amid the accelerating aging trend, addressing mild cognitive impairment (MCI) is critical for dementia prevention. Current evidence suggests that standalone interventions have limited efficacy, whereas combined physical‑cognitive training may yield greater benefits. However, the neurophysiological mechanisms of sequential combinations, particularly their effects on regional brain activation and functional connectivity, remain unclear. Functional near‑infrared spectroscopy (fNIRS) offers a non‑invasive tool to measure cortical oxygenation and address this gap. This 12‑week, three‑arm randomized controlled trial (RCT) will enroll 186 older adults with MCI to systematically compare sequential Baduanjin exercise (BE) followed by cognitive training (CT), BE alone, and CT alone. The primary cognitive outcome is global cognitive function, assessed with the Montreal Cognitive Assessment (MoCA). The primary neurophysiological outcome is the resting‑state change in oxyhaemoglobin (oxy‑Hb) concentration in the prefrontal (PFC), premotor (PMC), and supplementary motor (SMA) cortices, measured by fNIRS. Secondary outcomes include specific cognitive domain performance, balance, activities of daily living (ADL), resting heart rate, and heart rate variability (HRV). All measures will be assessed at baseline, immediately post‑intervention (week 12), and at a 4‑week follow‑up (week 16). This study aims to evaluate the efficacy of sequential BE followed by CT in improving cognitive function in older adults with MCI. By quantifying fNIRS‑derived PFC‑PMC‑SMA activation and connectivity, the research will elucidate how BE optimizes the neurophysiological milieu to enhance the targeted effects of CT on cognition. The findings will provide evidence for personalized multimodal interventions and advance the understanding of non‑pharmacological MCI management. Chinese Clinical Trial Registry ChiCTR2500112116. Registered 10 November 2025.
- 25 June 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Open AccessEffects of Baduanjin combined with cognitive training in older adults with mild cognitive impairment of mixed etiologies: a study protocol for a randomized controlled trial
Amid the accelerating aging trend, addressing mild cognitive impairment (MCI) is critical for dementia prevention. Current evidence suggests that standalone interventions have limited efficacy, whereas combined physical‑cognitive training may yield greater benefits. However, the neurophysiological mechanisms of sequential combinations, particularly their effects on regional brain activation and functional connectivity, remain unclear. Functional near‑infrared spectroscopy (fNIRS) offers a non‑invasive tool to measure cortical oxygenation and address this gap. This 12‑week, three‑arm randomized controlled trial (RCT) will enroll 186 older adults with MCI to systematically compare sequential Baduanjin exercise (BE) followed by cognitive training (CT), BE alone, and CT alone. The primary cognitive outcome is global cognitive function, assessed with the Montreal Cognitive Assessment (MoCA). The primary neurophysiological outcome is the resting‑state change in oxyhaemoglobin (oxy‑Hb) concentration in the prefrontal (PFC), premotor (PMC), and supplementary motor (SMA) cortices, measured by fNIRS. Secondary outcomes include specific cognitive domain performance, balance, activities of daily living (ADL), resting heart rate, and heart rate variability (HRV). All measures will be assessed at baseline, immediately post‑intervention (week 12), and at a 4‑week follow‑up (week 16). This study aims to evaluate the efficacy of sequential BE followed by CT in improving cognitive function in older adults with MCI. By quantifying fNIRS‑derived PFC‑PMC‑SMA activation and connectivity, the research will elucidate how BE optimizes the neurophysiological milieu to enhance the targeted effects of CT on cognition. The findings will provide evidence for personalized multimodal interventions and advance the understanding of non‑pharmacological MCI management. Chinese Clinical Trial Registry ChiCTR2500112116. Registered 10 November 2025.
- Open Access
- 3 June 2025
- Published by Springer Nature in BMC Psychology
- Vol. 13 (1) , 1-10
Cognitive and emotional benefits of individual reminiscence therapy in elderly stroke survivors: study protocol for a randomized controlled study
Post-stroke cognitive impairment (PSCI) and depression affect over 60% of elderly stroke survivors, severely impairing functional recovery and quality of life. Despite the efficacy of non-pharmacological interventions, evidence on individualized approaches for elderly stroke patients remains limited. This study aims to evaluate the clinical impact of individual reminiscence therapy (RT) on cognitive function, depressive symptoms, and quality of life in elderly stroke survivors. A single-blinded, parallel, randomized controlled trial will be conducted with 80 elderly stroke patients recruited from two hospitals in Shanghai. Participants will be randomly assigned to an intervention group receiving eight weeks of individual RT (30–45 min weekly) or a control group receiving standard care with a 1:1 ratio. Cognitive function, including Mini-Mental State Examination (MMSE), Boston Naming Test (BNT), Trail Making Test-A (TMT-A), depressive symptoms assessed by the Patient Health Questionnaire-9 (PHQ-9), and quality of life assessed by the Stroke-Specific Quality of Life Scale (Ss-QoL) will be assessed by blinded evaluators at baseline (T0), post-intervention (8 weeks, T1), and 4-week follow-up (12 weeks, T2). The intervention features a tailored RT protocol allowing patients to select topics (e.g., childhood memories, work life) to enhance engagement. Blinded evaluators will ensure measurement objectivity, and intention-to-treat analysis addressed attrition. This study aims to provide a fresh perspective on the effectiveness of individual RT in enhancing cognitive function, reducing depressive symptoms, and improving the quality of life, among stroke patients. The use of a tailored individual RT program based on an in-depth literature review and conceptual analysis, along with a multidimensional assessment system, differentiates this study from previous ones. This protocol was registered at the Chinese Clinical Trials.gov (Identifier: ChiCTR2500095471) on January 8, 2025.
- 3 June 2025
- Published by Springer Nature in BMC Psychology
- Vol. 13 (1) , 1-10
Open AccessCognitive and emotional benefits of individual reminiscence therapy in elderly stroke survivors: study protocol for a randomized controlled study
Post-stroke cognitive impairment (PSCI) and depression affect over 60% of elderly stroke survivors, severely impairing functional recovery and quality of life. Despite the efficacy of non-pharmacological interventions, evidence on individualized approaches for elderly stroke patients remains limited. This study aims to evaluate the clinical impact of individual reminiscence therapy (RT) on cognitive function, depressive symptoms, and quality of life in elderly stroke survivors. A single-blinded, parallel, randomized controlled trial will be conducted with 80 elderly stroke patients recruited from two hospitals in Shanghai. Participants will be randomly assigned to an intervention group receiving eight weeks of individual RT (30–45 min weekly) or a control group receiving standard care with a 1:1 ratio. Cognitive function, including Mini-Mental State Examination (MMSE), Boston Naming Test (BNT), Trail Making Test-A (TMT-A), depressive symptoms assessed by the Patient Health Questionnaire-9 (PHQ-9), and quality of life assessed by the Stroke-Specific Quality of Life Scale (Ss-QoL) will be assessed by blinded evaluators at baseline (T0), post-intervention (8 weeks, T1), and 4-week follow-up (12 weeks, T2). The intervention features a tailored RT protocol allowing patients to select topics (e.g., childhood memories, work life) to enhance engagement. Blinded evaluators will ensure measurement objectivity, and intention-to-treat analysis addressed attrition. This study aims to provide a fresh perspective on the effectiveness of individual RT in enhancing cognitive function, reducing depressive symptoms, and improving the quality of life, among stroke patients. The use of a tailored individual RT program based on an in-depth literature review and conceptual analysis, along with a multidimensional assessment system, differentiates this study from previous ones. This protocol was registered at the Chinese Clinical Trials.gov (Identifier: ChiCTR2500095471) on January 8, 2025.